Chronic Achilles tendinopathy is a persistent overuse injury that frequently sidelines athletes in running, jumping, and cutting sports. Unlike acute tendinitis, which involves inflammation, tendinopathy reflects degenerative changes within the tendon structure, often driven by repetitive overload and inadequate recovery. Managing this condition demands a comprehensive, evidence-based approach that addresses pain, restores function, and minimizes the risk of recurrence. This article outlines best practices for evaluating and treating chronic Achilles tendinopathy in athletes, integrating current research and clinical guidelines.

Understanding Chronic Achilles Tendinopathy

The Achilles tendon, the largest and strongest tendon in the human body, transmits forces from the gastrocnemius and soleus muscles to the calcaneus. Under repetitive high loads, the tendon’s collagen matrix can undergo microtearing and failed healing, leading to a condition known as tendinopathy. Histologically, this involves collagen disorganization, increased ground substance, neovascularization, and the absence of inflammatory cells—hence the preference for “tendinopathy” over “tendinitis.”

Chronic Achilles tendinopathy is classified by location: mid‑portion (2–6 cm proximal to the insertion) and insertional (affecting the calcaneal attachment). Mid‑portion tendinopathy is more common in runners and accounts for roughly 75% of cases, while insertional tendinopathy may be associated with Haglund’s deformity or retrocalcaneal bursitis. The chronic phase is defined by symptoms lasting longer than three months, often with a history of recurrent flare‑ups.

Pathophysiology and Failed Healing

Repetitive tensile and compressive forces disrupt the delicate equilibrium between collagen synthesis and degradation. Over time, tenocytes undergo apoptosis, the extracellular matrix becomes disorganized, and mucoid degeneration occurs. The tendon loses its viscoelastic properties, becomes less able to store and release energy, and develops painful nodular thickening. This degenerative state is often accompanied by neovascularisation and sensory nerve ingrowth, which may contribute to pain. Importantly, the condition is not inflammatory in the classical sense, which explains why anti‑inflammatory medications like NSAIDs have limited efficacy for long‑term recovery.

Risk Factors

Intrinsic and extrinsic factors interact to increase the likelihood of developing chronic Achilles tendinopathy. Athletic training errors—such as sudden increases in mileage, intensity, or frequency—are the most common precipitants. Additional factors include:

  • Biomechanical abnormalities: overpronation, supination, limited ankle dorsiflexion, and reduced calf flexibility.
  • Muscle imbalances: weak gluteals, hip stabilizers, or core musculature that alter lower‑limb loading.
  • Age and sex: incidence peaks in the 30–50 age range; men are affected more often than women.
  • Systemic conditions: diabetes, hypertension, hypercholesterolemia, and obesity are associated with tendinopathy.
  • Footwear and surface: worn‑out shoes, running on hard or uneven terrain, and inadequate footwear support.

Clinical Assessment and Diagnosis

A thorough clinical evaluation is the cornerstone of diagnosis. Imaging is reserved for cases where the diagnosis is uncertain, when there is suspicion of a tear, or before considering surgical intervention.

History and Symptoms

Athletes typically report gradual‑onset pain in the posterior heel or along the tendon at the start of activity that lessens as they warm up, only to return after cessation of exercise. In chronic cases, pain may become constant and interfere with daily activities such as stair climbing or walking. Morning stiffness and a feeling of stiffness after prolonged sitting (the “first‑step” pain) are characteristic. The athlete may also describe a palpable lump or thickening in the tendon.

Physical Examination

  • Inspection and palpation: Look for swelling, erythema (rare in chronic cases), and a palpable nodule along the mid‑tendon or at the insertion. Tenderness is most pronounced with direct palpation of the painful segment.
  • Range of motion: Assess ankle dorsiflexion with the knee both flexed and extended (to differentiate gastrocnemius versus soleus tightness). Reduced dorsiflexion increases tension on the Achilles.
  • Strength testing: Perform single‑leg heel raises (full range and eccentric) to evaluate calf endurance and pain response. The “Royal London Hospital test” (pain on resisted dorsiflexion or eccentric loading) is highly sensitive.
  • Gait analysis: Observe the athlete walking and running. Look for excessive pronation, a bent‑knee gait, or a lack of heel‑strike, which may indicate compensatory strategies.
  • Special tests: The Thompson test (squeezing the calf to elicit plantarflexion) is used to rule out an Achilles rupture.

Imaging Studies

Ultrasound is often the first‑line imaging modality, as it can detect tendon thickening, hypoechoic areas, and neovascularisation on Doppler. MRI provides superior soft‑tissue resolution and can differentiate between intrasubstance degeneration, partial tears, and paratendinopathy. Imaging is not required for the initial diagnosis but can be helpful when symptoms fail to respond to conservative care or when a surgical decision is pending.

Link: For detailed imaging guidelines, see the American Academy of Orthopaedic Surgeons clinical practice summary on Achilles tendinopathy.

Differential Diagnosis

Several conditions can mimic chronic Achilles tendinopathy and must be ruled out:

  • Retrocalcaneal bursitis: pain and swelling at the posterior heel, often with compression between the Achilles and the calcaneus.
  • Paratenonitis: inflammation of the sheath surrounding the tendon (more common in runners with acutely increased mileage).
  • Haglund’s deformity: a bony prominence on the posterosuperior calcaneus that can cause insertional pain and bursitis.
  • Acute or chronic tendon rupture: history of trauma, sudden sharp pain, palpable gap, positive Thompson test.
  • Sural nerve entrapment: burning pain along the lateral heel and foot.

Conservative Management Strategies

More than 80% of athletes with chronic Achilles tendinopathy can be successfully managed non‑surgically. Treatment is guided by a progressive loading framework that respects tissue capacity without provoking excessive pain.

Initial Phase: Load Management and Pain Control

Relative rest—reducing or eliminating high‑impact activities—is essential during the first one to two weeks. Athletes can maintain cardiovascular fitness via cycling, swimming, or deep‑water running, which place minimal stress on the Achilles. Ice packs applied for 15–20 minutes after activity can help manage pain, but their long‑term efficacy is limited. While NSAIDs may offer temporary symptom relief, they are not recommended for chronic use because they do not address the degenerative pathology and may inhibit tendon healing. Instead, paracetamol or topical agents are safer alternatives.

Activity modification must be individualized. A simple rule is to avoid activities that cause more than 4/10 pain during or immediately after exercise. Pain should settle within 24 hours; if it persists, the load is too high.

Rehabilitation Phase: Progressive Loading

Strengthening the calf complex is the cornerstone of rehabilitation. The most evidence‑based approach is a combination of eccentric, concentric, and isometric exercises, often called heavy slow resistance (HSR) training.

  • Eccentric heel drops (Alfredson protocol): Standing on a step on the affected leg, slowly lower the heel below the step level (eccentric phase), then lift the heel back to neutral using both legs. Progress to added weight (backpack or dumbbells) as pain permits. Perform 3 sets of 15 repetitions twice daily.
  • Heavy slow resistance: Performed in a leg press or smith machine with a full range of motion (dorsiflexion through plantarflexion). Use a load of 8–12 RM (repetition maximum) for 3–4 sets, every second day. Research suggests HSR is equally effective as eccentric training but may be better tolerated.
  • Isometric holds: Holding a heel raise at end range (or mid‑range) for 30–60 seconds can provide short‑term pain relief and is useful as a warm‑up before activity.
  • Stretching: Gentle gastrocnemius and soleus stretches (holding for 30 seconds) should be performed after strengthening, but aggressive stretching during the acute phase may exacerbate pain.

Link: A landmark trial published in the British Journal of Sports Medicine (Beyer et al., 2015) compared eccentric training and HSR and found both effective, with HSR leading to better patient satisfaction.

Adjunctive Therapies

While not all are supported by high‑level evidence, several modalities are commonly integrated into care:

  • Extracorporeal shock wave therapy (ESWT): Delivering acoustic waves to the degenerative area may stimulate healing. It has shown benefit, particularly for chronic mid‑portion tendinopathy. Typically 3–5 sessions at weekly intervals are used.
  • Platelet‑rich plasma (PRP) injections: Though controversial, some systematic reviews suggest PRP may offer superior long‑term outcomes compared with placebo, especially for athletes who have failed first‑line rehabilitation. It is not recommended as a standalone treatment but may be combined with exercise.
  • Manual therapy: Soft‑tissue mobilization, cross‑friction massage, and instrument‑assisted techniques can help reduce adhesions and improve local circulation.
  • Orthotics and footwear: Heel lifts (5–10 mm) can offload the tendon initially. For runners with overpronation, motion‑control shoes or semi‑rigid orthotics may improve alignment.

Addressing Biomechanical Deficits

Athletes with chronic Achilles tendinopathy often exhibit altered gait mechanics, such as increased hip or knee flexion on the affected side (a compensatory pattern). A comprehensive program must address deficits throughout the kinetic chain. Key areas include:

  • Gluteal and hip strengthening: Exercises such as side‑lying hip abduction, clamshells, and single‑leg bridges to reduce hip adduction and internal rotation during stance.
  • Core stability: Planks, dead bugs, and anti‑rotation exercises to maintain a stable pelvis during gait.
  • Gait retraining: Instructing athletes to increase cadence (by 5–10%), reduce vertical oscillation, and adopt a more midfoot strike pattern can lower Achilles tendon load. Use of a metronome during runs can help.
  • Flexibility: Regular stretching of the gastrocnemius and soleus, as well as the hamstrings and quadriceps, reduces overall tension on the posterior chain.

Advanced Interventions

For the minority of athletes who do not improve after 3–6 months of structured conservative care, advanced treatments may be considered.

Injections

Multiple injection options exist, but evidence is mixed:

  • Corticosteroid injections: Generally avoided in chronic tendinopathy because of the risk of tendon rupture and limited evidence of long‑term benefit. They may be used sparingly for insertional tendinopathy where there is concomitant bursitis.
  • PRP injections: Leukocyte‑rich PRP has shown promise in several studies, while leukocyte‑poor PRP has been less effective. The Orthohealing trial (2015) reported improved outcomes over 12 months, especially in younger, more active patients.
  • Sclerosing injections (polidocanol): Injecting a sclerosant into neovessels under ultrasound guidance can reduce pain, but the procedure is less common now due to variable results.
  • High‑volume image‑guided injections (HVIGI): Instillation of a large volume of saline (with or without anaesthetic and corticosteroid) around the tendon may disrupt neovascularisation and adhesions.

Extracorporeal Shock Wave Therapy (ESWT)

For chronic mid‑portion Achilles tendinopathy, ESWT is supported by moderate‑quality evidence. Focused or radial shockwave is applied to the tender area. It may be used alone or in combination with eccentric exercise. A typical protocol involves 1–3 treatments spaced a week apart.

Surgical Options

Surgery is reserved for athletes who have failed a minimum of 6 months of comprehensive non‑operative management. The most common procedure is open debridement of the degenerative tissue, often combined with repair of the remaining tendon. For insertional tendinopathy, a Haglund’s resection and debridement of the retrocalcaneal bursa may be performed. In some cases, a gastrocnemius recession (lengthening) is added to reduce tension, particularly when ankle dorsiflexion is limited. Postoperatively, a structured rehabilitation programme lasting 6–12 months is needed to recover strength and function.

Link: A recent review of surgical outcomes in athletes can be accessed through the Journal of Sports Medicine and Arthroscopy Review.

Return to Sport Criteria

Returning to sport without adequate rehabilitation invites recurrence—rates can exceed 30% within two years. A phased return is recommended:

  • Phase 1 (pain control and early loading): Achieve pain‑free walking, gain full ankle range of motion, and perform pain‑free isometric contractions.
  • Phase 2 (strengthening): Perform single‑leg heel raises for at least 20 repetitions with good form. Eccentric and HSR loads should be pain‑free during and after exercise.
  • Phase 3 (sport‑specific training): Begin running with a walk‑run interval program (e.g., 1 min run / 2 min walk, progressing to continuous running). Incorporate agility drills, plyometrics (e.g., box jumps, bounding) gradually.
  • Phase 4 (return to full sport): The athlete should have no pain during or after sport‑specific activity, demonstrate strength symmetry (less than 10% deficit in calf raise endurance and hopping performance compared with the unaffected side), and have completed at least two weeks of full‑load training without flare‑ups.

It is important to note that a pain‑free tendon on palpation does not necessarily indicate full recovery; structural changes may persist. The decision to return should be based on functional capacity rather than imaging findings.

Prevention

Given the high recurrence rate, prevention strategies are as vital as treatment. Key principles include:

  • Load management: Follow the “10% rule” (increase weekly running mileage or training volume by no more than 10%). Incorporate deload weeks every 3–4 weeks.
  • Strength foundation: Maintain calf‑strengthening exercises (eccentric and concentric) twice weekly even during the in‑season. Hip and core strengthening should be a year‑round priority.
  • Flexibility and mobility: Daily calf stretching, particularly after training, can offset stiffness. Foam rolling of the calves and ankles also helps maintain tissue quality.
  • Footwear: Replace running shoes every 300–500 miles. Consider a shoe with a slightly lower heel‑to‑toe drop if Achilles pain is chronic, but transition gradually.
  • Biomechanical screening: A gait analysis by a physiotherapist or running specialist can identify risky patterns before they cause injury. The presence of tight calves or a stiff ankle gait should be addressed proactively.

Prognosis and Long‑Term Management

With appropriate conservative management, 60–90% of athletes with chronic Achilles tendinopathy can return to their previous level of sport within 6–12 months. However, a subset will have lingering pain or stiffness for years. Long‑term management involves periodic refresher phases of strengthening, careful load monitoring, and continued attention to biomechanical risk factors. For athletes who undergo surgery, outcomes are generally favourable, but recovery is prolonged (often 9–18 months before pain‑free sprinting). Recurrence after surgery is lower than after conservative care alone but still reported in 10–15% of cases.

Conclusion

Managing chronic Achilles tendinopathy in athletes requires a patient‑centred, evidence‑informed approach that prioritizes progressive loading, identifies and treats underlying risk factors, and guides return to sport through objective functional criteria. Most athletes recover with conservative measures such as eccentric or heavy slow resistance training, supplemented by modalities like ESWT or PRP when needed. Surgical intervention remains a viable option for the persistent few. By adopting best practices—early assessment, structured rehabilitation, and ongoing prevention—clinicians can help athletes overcome this challenging condition and sustain long‑term athletic performance.